In this article, we will take a look at the 10 stocks in focus after posting their earnings reports.
Recently, stocks from the consumer cyclical and healthcare sectors, including Lowe’s Companies, Inc. (NYSE:LOW), The TJX Companies, Inc. (NYSE:TJX), Teladoc Health, Inc. (NYSE:TDOC) and Agilent Technologies, Inc. (NYSE:A), came out with the financial results for their respective quarters.
If we look at their price actions, shares of Teladoc Health, Agilent Technologies and TJX Companies turned red after releasing their earnings reports. On the other hand, Lowe’s shares marginally moved up after beating expectations.
However, if we look at the broader market, all major U.S. indices were down amid heightening tensions between Russia and Ukraine. Just before the opening bell on Thursday, February 24, S&P 500 was down 2.33 percent, Dow Jones Industrial Average was minus 2.27 percent and Nasdaq Composite Index was negative 2.90 percent.

Stocks in Focus After Posting Their Earnings Reports
10. Penumbra, Inc. (NYSE:PEN)
Number of Hedge Fund Holders: 23
Shares of Penumbra, Inc. (NYSE:PEN) slipped nearly six percent on Wednesday, February 23, 2022, following its disappointing earnings for the fourth quarter. The Alameda, Calif.-based medical device company reported adjusted earnings of 1 cent per share, missing the consensus of 22 cents per share with a big margin.
On the bright side, Penumbra, Inc. (NYSE:PEN) posted revenue of $204 million, up 23 percent versus last year and ahead of analysts’ average estimate of $194.30 million. If we break down the total sales by segments, vascular products revenue jumped 31.1 percent to $113.6 million, while neuro products revenue rose 14.1 percent to $90.4 million in the quarter.
Penumbra, Inc. (NYSE:PEN) also released its sales outlook for 2022. The company guided for revenue in the range of $860 – $875 million for the current fiscal year, representing a growth of 15 – 18 percent over last year.
9. Monday.com Ltd. (NASDAQ:MNDY)
Number of Hedge Fund Holders: 25
Shares of Monday.com Ltd. (NASDAQ:MNDY) recently plunged to an all-time low despite posting a narrower-than-expected loss for the fourth quarter. The Israel-based software company reported an adjusted loss of 26 cents per share, compared to a loss of 64 cents per share in the year-ago period.
Revenue for the quarter climbed 91 percent on a year-over-year basis to $95.5 million. Analysts were expecting Monday.com Ltd. (NASDAQ:MNDY) to report a loss of 52 cents per share on revenue of $87.8 million.
Looking forward, Monday.com Ltd. (NASDAQ:MNDY) expects revenue in the range of $100 – $102 million for the first quarter and between $470 – $475 million for the full year. This compares to the consensus of $94.1 million for Q1 and $443.1 million for 2022.
Like Monday.com Ltd. (NASDAQ:MNDY), investors are also keeping an eye on Lowe’s Companies, Inc. (NYSE:LOW), The TJX Companies, Inc. (NYSE:TJX) and Teladoc Health, Inc. (NYSE:TDOC) following their earnings reports.
8. Molson Coors Beverage Company (NYSE:TAP)
Number of Hedge Fund Holders: 33
Shares of Molson Coors Beverage Company (NYSE:TAP) rose to a one-month high on Wednesday, February 23, 2022, after releasing its fourth-quarter results. The Illinois-based drink and brewing company reported adjusted earnings of 81 cents per share, representing a surge of more than two-folds from the year-ago period.
In addition, Molson Coors Beverage Company (NYSE:TAP) posted revenue of $2.62 billion, up 14.2 percent on a year-over-year basis. Analysts were looking for earnings of 85 cents per share on revenue of $2.55 billion.
Molson Coors Beverage Company (NYSE:TAP) also reported its region-wise sales numbers. Revenue from the Americas segment rose 7.6 percent in the quarter, while revenue from the EMEA&APAC segment climbed 56.4 percent.
Commenting on the results, CFO Tracey Joubert said in a statement:
“For the year, we achieved our top-line guidance of mid single-digit growth, delivered strong free cash flow, further reduced our leverage ratio, and returned cash to shareholders all despite the global macro inflationary challenges.”
7. Vertiv Holdings Co (NYSE:VRT)
Number of Hedge Fund Holders: 33
Shares of Vertiv Holdings Co (NYSE:VRT) took a deep dive on Wednesday, February 23, 2022, hitting a nearly 20-month low, following its weak financial performance for the fourth quarter.
Vertiv Holdings Co (NYSE:VRT) reported adjusted earnings of 4 cents per share on revenue of $1.41 billion. The results fell short of analysts’ average estimate of 28 cents per share for earnings and $1.42 billion for revenue.
For the first quarter, Vertiv Holdings Co (NYSE:VRT) expects revenue in the range of $1.1 – billion. Moreover, it expects to generate revenue between $5.5 – $5.8 billion for the full year. On the other hand, analysts were looking for revenue of $1.27 billion for Q1 and $5.73 billion for 2022.
Like Vertiv Holdings Co (NYSE:VRT), Lowe’s Companies, Inc. (NYSE:LOW), The TJX Companies, Inc. (NYSE:TJX) and Teladoc Health, Inc. (NYSE:TDOC) also came into the spotlight after releasing their financial results.
6. Exact Sciences Corporation (NASDAQ:EXAS)
Number of Hedge Fund Holders: 34
Exact Sciences Corporation (NASDAQ:EXAS) recently announced better-than-expected sales for the fourth quarter. However, its quarterly loss was wider than expectations, sending its shares down over six percent on Wednesday, February 23, 2022.
The Wisconsin-based molecular diagnostics company reported a loss of $1.28 per share, compared to a loss of $2.67 per share it reported for the fourth quarter of 2020. On the other hand, analysts expected Exact Sciences Corporation (NASDAQ:EXAS) to report a loss of $1.04 per share.
Revenue came in at $473.8 million, up 2 percent versus last year and better than the consensus of $449 million. Exact Sciences Corporation (NASDAQ:EXAS) also disclosed the sales numbers of its flagship products and segments.
Screening revenue for the quarter rose 11 percent to $277.7 million, while Precision Oncology revenue climbed 27 percent to $149 million. On the downside, coronavirus testing revenue plummeted 52 percent to $47.1 million.
Exact Sciences Corporation (NASDAQ:EXAS) also released its sales outlook for the full year. It projected revenue of $1.97 – $2.03 billion versus analysts’ average estimate of $1.99 billion. Screening revenue is expected to come between $1.34 – 1.37 billion, Precision Oncology revenue in the range of $595 – $610 million and coronavirus testing revenue between $40 – $50 million.
Speaking on the results, CEO Kevin Conroy said:
“Cologuard® and Oncotype DX® are off to a great start in 2022, with strong momentum from the fourth quarter carrying over to the new year. We have a team of talented people dedicated to defeating cancer. You’ll see the results of their dedication this year as we test more patients and share evidence supporting our pipeline of innovative tests across the cancer continuum.”
5. Teladoc Health, Inc. (NYSE:TDOC)
Number of Hedge Fund Holders: 39
Teladoc Health, Inc. (NYSE:TDOC) recently announced better-than-expected financial results for the fourth quarter. However, its first-quarter outlook was below expectations, sending its shares down nearly six percent on Wednesday, February 23, 2022.
The telemedicine company reported a loss of 7 cents per share, narrower than the loss of $3.07 per share in the same period of 2020. Analysts expected Teladoc Health, Inc. (NYSE:TDOC) to report a loss of 56 cents per share.
Follow Teladoc Health Inc. (NYSE:TDOC)
Follow Teladoc Health Inc. (NYSE:TDOC)
Receive real-time insider trading and news alerts
Revenue for the quarter jumped 45 percent on a year-over-year basis to $554.2 million, topping expectations of $545.61 million. Teladoc Health, Inc. (NYSE:TDOC) also released its segment-wise sales figures. Its access fees revenue for the quarter climbed 51 percent to $469.9 million, while visit fee revenue rose 21 percent to $68.9 million.
Looking forward, Teladoc Health, Inc. (NYSE:TDOC) guided for a loss in the range of 60 – 50 cents per share and revenue between $565 – $571 million for the first quarter. The outlook missed analysts’ average estimate for a loss of 51 cents per share on revenue of $588.94 million.
4. Agilent Technologies, Inc. (NYSE:A)
Number of Hedge Fund Holders: 41
Shares of Agilent Technologies, Inc. (NYSE:A) recently fell to a nearly one-year low despite posting its fiscal first-quarter profit and sales above expectations. The company earned $1.21 per share in the quarter, up from $1.06 per share in the year-ago period.
In addition, Agilent Technologies, Inc. (NYSE:A) posted revenue of $1.67 billion, translating to a surge of 8 percent on a year-over-year basis. The results exceeded analysts’ average estimate of $1.03 per share for earnings and $1.46 billion for revenue.
Follow Agilent Technologies Inc. (NYSE:A)
Follow Agilent Technologies Inc. (NYSE:A)
Receive real-time insider trading and news alerts
Agilent Technologies, Inc. (NYSE:A) also issued the financial outlook for its fiscal second quarter. It expects adjusted earnings in the range of $1.10 – $1.12 per share and revenue between $1.59 – $1.62 billion for the current quarter.
In addition, Agilent Technologies, Inc. (NYSE:A) raised its FY 2022 outlook to a range of $6.67 – $6.73 billion, representing a surge between 5.6 – 6.5 percent over last year.
Commenting on the quarter, CEO Mike McMullen said:
“Building on our first quarter results, combined with a strong order book, we are raising our full year outlook, increasing our core growth and non-GAAP EPS expectations. The Agilent portfolio and team have never been stronger. I’m confident we will continue our outstanding execution for the remainder of the year.”
3. RingCentral, Inc. (NYSE:RNG)
Number of Hedge Fund Holders: 47
Shares of RingCentral, Inc. (NYSE:RNG) recently hit a new 52-week low even after delivering solid profit and sales for the fourth quarter. The company reported adjusted earnings of 39 cents per share, topping expectations of 37 cents per share.
Revenue for the quarter rose 34 percent on a year-over-year basis to $448 million, exceeding the consensus of $434.94 million. Subscription revenue jumped 37 percent to $420 million and represented more than 90 percent of the total quarterly sales.
Follow Ringcentral Inc. (NYSE:RNG)
Follow Ringcentral Inc. (NYSE:RNG)
Receive real-time insider trading and news alerts
Looking forward, RingCentral, Inc. (NYSE:RNG) expects adjusted earnings of around 34 cents per share for the first quarter. Moreover, revenue for the same period is expected to come in between $455 – $459 million, translating to a surge between 29 – 30 percent over last year.
Discussing the results, CEO of RingCentral, Inc. (NYSE:RNG), Vlad Shmunis, said:
“Fourth quarter results were outstanding, driven by continued momentum with upmarket customers and ramping contributions from our key partners. Our commitment to innovation is driving a rapid pace of new, business-oriented capabilities across our RingCentral Message Video Phone and integrated cloud contact center solutions, and we’ve meaningfully expanded our differentiated market access with our newest exclusive strategic partner, Mitel.”
2. The TJX Companies, Inc. (NYSE:TJX)
Number of Hedge Fund Holders: 56
Shares of The TJX Companies, Inc. (NYSE:TJX) plunged to a nearly 15-month on Wednesday, February 23, 2022, after the Massachusetts-based off-price retail giant failed to meet profit and sales expectations for its fiscal fourth quarter.
The TJX Companies, Inc. (NYSE:TJX) earned 78 cents per share, up from 27 cents per share in the year-ago period. Revenue for the quarter rose 27 percent on a year-over-year basis to $13.9 billion. The results missed the consensus forecast of 91 cents per share for earnings and $14.26 billion for revenue.
Follow Tjx Companies Inc (NYSE:TJX)
Follow Tjx Companies Inc (NYSE:TJX)
Receive real-time insider trading and news alerts
The TJX Companies, Inc. (NYSE:TJX) also released its earnings outlook for the first quarter. It guided for earnings in the range of 58 – 61 cents per share, in line with analysts’ average estimate of 59 cents per share.
Speaking on the results, CEO Ernie Herrman said in a statement:
“Our home businesses across all of our divisions delivered phenomenal open-only comp store sales performance, and overall apparel open-only comp store sales increased high-single digits in Fiscal 2022. While freight and wage cost pressures remain elevated, we are pleased that our retail pricing strategy is working very well.”
1. Lowe’s Companies, Inc. (NYSE:LOW)
Number of Hedge Fund Holders: 72
Shares of Lowe’s Companies, Inc. (NYSE:LOW) slightly moved up on Wednesday, February 23, 2022, following its upbeat financial performance for the fourth quarter. The home improvement retailer earned $1.78 per share, compared to $1.32 per share in the fourth quarter of 2020.
Revenue for the quarter improved 5 percent versus last year to $21.3 billion. Analysts were expecting Lowe’s Companies, Inc. (NYSE:LOW) to report earnings of $1.70 per share on revenue of $20.87 billion.
Follow Lowes Companies Inc (NYSE:LOW)
Follow Lowes Companies Inc (NYSE:LOW)
Receive real-time insider trading and news alerts
Looking forward, Lowe’s Companies, Inc. (NYSE:LOW) lifted its FY 2022 earnings outlook to a range of $13.10 – $13.60 per share, compared to its earlier projection between $12.25 – $13 per share. The revised outlook is above the consensus of $12.94 per share.
Discussing the results, CEO Marvin Ellison said in a statement:
“In 2021, we increased comparable sales by 6.9% while generating over 170 basis points of operating margin improvement, with our relentless focus on productivity and enhanced pricing strategies. We remain confident in the long-term strength of the home improvement market, and our ability to expand operating margin.”
You can also take a peek at Jim Cramer’s Top 10 Stock Picks for 2022 and Top 10 Stock Picks of Thomas Bancroft’s Makaira Partners.
Follow Insider Monkey on Twitter
Suggested articles:
- Billionaire Leon Cooperman Is Buying These 10 Stocks
- 10 Best Metaverse ETFs To Buy
- 10 Best Pharmaceutical Stocks to Buy in 2022
Disclosure: None. 10 Stocks in Focus After Posting Their Earnings Reports is originally published on Insider Monkey



